drugs
|
specialties
|
UnregisterUser
|
IsNClickFreeLimitExceeded: True
|
NClickFreeLimit: 0
|
Download App
Myanmar
search
Sign in
Home
Find Drugs
Pill Identifier
Find Drug Company
Country
China
Hong Kong
India
Indonesia
Malaysia
Myanmar
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
search
UserName
Profession
Email
Account
Manage Account
Change Password
Sign Out
Home
Find Drugs
Pill Identifier
Find Drug Company
Others Services
Download App
Myanmar
China
Hong Kong
India
Indonesia
Malaysia
Myanmar
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
More Services
drugs
|
specialties
|
UnregisterUser
|
IsNClickFreeLimitExceeded: True
|
NClickFreeLimit: 0
|
Manage Account
Sign in
Home
Find Drugs
Pill Identifier
Find Drug Company
MIMS home
Drugs
Info
Sanglif
Sanglif
canagliflozin
Manufacturer:
Healthcare Pharma
Distributor:
San Lwin Trading
Marketer:
San Lwin Trading
SELECT
Concise Prescribing Info
Full Prescribing Info
Contents
Description
Action
Indications/Uses
Dosage/Direction for Use
Contraindications
Special Precautions
Use In Pregnancy & Lactation
Side Effects
Drug Interactions
Storage
MIMS Class
ATC Classification
Regulatory Classification
Presentation/Packing
Concise Prescribing Info
Full Prescribing Info
Contents
Description
Action
Indications/Uses
Dosage/Direction for Use
Contraindications
Special Precautions
Use In Pregnancy & Lactation
Side Effects
Drug Interactions
Storage
MIMS Class
ATC Classification
Regulatory Classification
Presentation/Packing
Concise Prescribing Info
Contents
Canagliflozin
Indications/Uses
Adjunct to diet & exercise to improve glycemic control in adults w/ type 2 DM.
Click to view Sanglif detailed prescribing information
Dosage/Direction for Use
Recommended starting dose: 100 mg once daily.
Patients w/ eGFR 60 mL/min/1.73 m
2
300 mg once daily.
Patients w/ eGFR 45 to <60 ml/min/1.73 m
2
100 mg once daily.
Click to view Sanglif detailed prescribing information
Administration
May be taken with or without food: Preferably taken before the 1st meal of the day.
Contraindications
History of hypersensitivity. Severe renal impairment; end stage renal disease (ESRD); dialysis patients.
Click to view Sanglif detailed prescribing information
Special Precautions
Type 1 DM or diabetic ketoacidosis.
Click to view Sanglif detailed prescribing information
Use In Pregnancy & Lactation
Click to view Sanglif detailed prescribing information
Adverse Reactions
Female genital mycotic infections, UTI, increased urination, low BPH & blood glucose, increased blood K levels (hyperkalemia) & low-density-lipoprotein (LDL-C).
Drug Interactions
Reduced exposure of UGT inducers eg, rifampin, phenytoin. Slightly increased digoxin conc.
Click to view Sanglif detailed prescribing information
Storage
View
Sanglif storage
conditions for details to ensure optimal shelf-life.
Description
View
Sanglif description
for details of the chemical structure and excipients (inactive components).
Action
View
Sanglif mechanism of action
for pharmacodynamics and pharmacokinetics details.
MIMS Class
Antidiabetic Agents
ATC Classification
A10BK02 - canagliflozin ; Belongs to the class of sodium-glucose co-transporter 2 (SGLT2) inhibitors. Used in the treatment of diabetes.
Regulatory Classification
POM
Presentation/Packing
Form
Sanglif FC tab 100 mg
Packing/Price
1 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Continue with Google
OR
Sign Up
Already a member?
Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Continue with Google
OR
Sign Up
Already a member?
Sign in
Sign Out
